Last week, the White House announced a 100% Section 232 tariff on large drones and critical components, citing their dual-use applications. The duties are set to take effect on September 3.
USCBC interviews Jane Nakano, senior fellow at the Center for Strategic and International Studies’s Energy Security and Climate Change Program, on China’s energy landscape. Topics include impacts of the war in Iran, challenges in China’s decarbonization push, the role of energy in US-China tech competition, and areas for foreign participation.
China has seen a series of high-level personnel changes at both the central and provincial levels in recent months, driven by appointments made around the national and local Two Sessions as well as developments in the ongoing anti-corruption campaign.
Tension is building just a week before Trump’s high-stakes visit to China, and US officials are tempering expectations. Treasury Secretary Scott Bessent on Monday downplayed deliverables for the summit, set for May 14 to 15, noting only that the United States will “push forward the consensus” reached with China last year.
USCBC interviews Fraser Howie, co-author of three books on the Chinese financial system, on how China’s stock market has evolved over the past 25 years, factors behind country’s managed exchange rate, and efforts to internationalize the yuan.
Just six days after issuing the Regulations on Industrial and Supply Chain Security (Doc. 834), China’s State Council released the Regulations on Countering Foreign States’ Improper Extraterritorial Jurisdiction (Doc. 835), another expansion of Beijing’s retaliatory toolkit. Unlike Doc. 834, which governs sectoral and commercial supply chain security and is triggered by a demonstrable harm or threat, Doc. 835 targets foreign legal pressure itself regardless of commercial impact and can therefore be invoked under a lower evidentiary threshold.
In a pivot toward greater flexibility for public healthcare institutions, central government regulators recently introduced a series of measures to provide patients with differentiated, tiered products and services based on factors like clinical value, patient segmentation, and local fiscal capacity. The shift incentivizes innovation by driving more promising returns on R&D investments.
According to official government data, China’s real GDP grew 5% year-on-year in the first three months of 2026 to 33.42 trillion yuan ($4.9 trillion), beating expectations and reversing the downward trend seen in the second half of 2025. Strong industrial output and foreign trade drove growth, but weak demand weighed on overall activity and clouds the outlook for the rest of the year.
The House Foreign Affairs Committee on Wednesday advanced all 23 export controls related bills included in its markup, sending a strong message of support for enhanced controls and enforcement. Several bills, including the ADVERSARIES Act and STRIDE Act, passed unanimously, with most others receiving broad, bipartisan support.
China’s State Council issued the Regulations on Industrial Chain and Supply Chain Security on April 7, creating a mechanism to monitor and investigate supply chain risks. Investigations could lead to countermeasures against countries, companies, and other entities. While the rules don’t necessarily create new retaliatory tools, they connect China’s existing tools under one framework, embedding retaliation into China’s governance system.
This week, the United States and China affirmed that President Donald Trump’s visit to China is expected to go ahead despite mixed signals from the administration over China’s relationship with Iran. Trump on Tuesday met with US Ambassador to China David Perdue in Washington to discuss summit planning, but no details have been shared.
